FOAMcast -  Emergency Medicine Core Content
FOAMcast - Emergency Medicine Core Content
FOAMcast
We believe in the educational merits of Free Open Access Medical education (FOAM), which includes podcasts, blogs, articles on PubMed Central, conferences streamed for free and more. As a result, we would like to encourage others to move beyond quoting podcasts and into the realm of tying “cutting edge” FOAM to the core content. We’ll provide some review and references for listeners to go read. Why, indeed, should we FOAM it alone when FOAM can inspire us to go, read, think, and be excellent?
COVIDcast: SARS-CoV-2 Vaccine Update
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* Vaccines for SARS-CoV-2 have been in development for only a few months, but several have published early results from Phase III efficacy trials in press releases. In this episode, we review these vaccines and what we know about them, and what we know about  them Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Nov 29
25 min
Cannabinoid Hyperemesis Syndrome
In this episode, we review cannabinoid hyperemesis syndrome and two recent randomized controlled trials on treatments Haloperidol - Ruberto et al  (Annals of Emergency Medicine, In Press) Capsaicin - Dean et al. Acad Emerg Med 2020. Show notes (references, graphics) at FOAMcast.org Thanks for listening! Jeremy Faust and Lauren Westafer
Nov 27
21 min
COVIDcast - Tocilizumab
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* Monoclonal antibodies have received significant attention over the past month and we previously podcasted on antibodies that target SARS-CoV-2. In this episode, we review several recent studies on a different "mab", tocilizumab,  which targets inflammation mediated by interleukin-6 that is overly ramped up.  We review: Stone et al  ( RCT) Hermine et al (RCT) Salvarani et al. (RCT) STOP-COVID (observational) Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Oct 24
20 min
COVIDcast: Monoclonal Antibodies
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* Monoclonal antibodies have received significant attention over the past couple of weeks. In this episode, we review what we know, as of October 9, 2020, about monoclonal antibodies as a therapy for COVID-19.  Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Oct 11
17 min
COVIDcast: High Flow Nasal Cannula and Health Care Worker Infections
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review a retrospective evaluation of COVID-19 infections in employees after a protocol that increased the use of high flow nasal cannula (Westafer et al) Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Oct 9
10 min
Lit Update: PE Risk Stratification Tool Performance (PESI, sPESI, BOVA)
We spoonfeed you a new article on risk stratification of pulmonary embolism (with critical appraisal pearls!) In this episode, we review a new trial by Barnes et al on antacids versus antacids with lidocaine for epigastric pain and dyspepsia Show notes and references at FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Sep 21
11 min
COVIDcast: Steroids in COVID-19
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review a new meta-analysis from the WHO REACT group of steroids in critically ill patients with COVID-19 and 3 new randomized trials of steroids in COVID-19 published in JAMA on September 2: REMAP-CAP COVID-19  CoDEX CAPE Covid Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Sep 3
15 min
COVIDcast: Convalescent Plasma Update
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review the evidence, to date, on convalescent plasma for the treatment of COVID-19. This includes 3 randomized trials, as well the US experience with >35,000 patients treated with convalescent plasma, a noncontrolled study by Joyner et al [pre-print]. Show notes (references/graphics): FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Aug 25
14 min
Remdesivir - A new open-label trial
We interrupt our normal FOAMcast episodes to bring you updates from COVID-19. *Our understanding of COVID-19 is rapidly developing and this may be out of date in days/weeks. So, check back for updates/fact check what you hear* We review Spinner et al in JAMA 2020, an open label trial of remdesivir 5 days vs remdesivir 10 days vs 'standard of care' for the treatment of #COVID19 Show notes: FOAMcast.org Thanks for listening, Lauren Westafer and Jeremy Faust
Aug 24
9 min
Metabolic Resuscitation in Sepsis - The ACTS Randomized Trial
 We review the Ascorbic Acid, Corticosteroids, and Thiamine in Septic Shock (ACTS) Trial by Moskowitz et al in JAMA Show notes: FOAMcast.org Thanks for listening! Jeremy Faust and Lauren Westafer
Aug 18
22 min
Load more